Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,320,800 | 337,500 | 426,800 | 316,600 | 433,600 |
| Receivables | 3,016,600 | 2,025,300 | 1,862,300 | 1,847,500 | 1,518,700 |
| Inventories | 423,200 | 244,700 | 237,300 | 227,200 | 205,200 |
| Other current assets | 0 | 0 | 0 | 33,700 | 0 |
| TOTAL | $5,125,400 | $2,981,200 | $2,835,400 | $2,733,800 | $2,478,700 |
| Non-Current Assets | |||||
| PPE Net | 2,729,600 | 2,636,600 | 1,740,300 | 1,706,600 | 1,718,600 |
| Investments And Advances | 73,500 | 84,900 | 60,500 | 58,400 | 57,600 |
| Intangibles | 11,712,600 | 11,899,500 | 11,271,400 | 11,567,000 | 9,824,900 |
| Other Non-Current Assets | 430,600 | 444,200 | 277,700 | 607,200 | 167,200 |
| TOTAL | $14,946,300 | $15,065,200 | $13,349,900 | $13,939,200 | $11,768,300 |
| Total Assets | $20,071,700 | $18,046,400 | $16,185,300 | $16,673,000 | $14,247,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 638,900 | 632,300 | 634,600 | 573,900 | 508,400 |
| Accrued Expenses | 1,357,700 | 942,400 | 870,000 | 793,300 | 593,700 |
| Other current liabilities | N/A | N/A | N/A | 20,200 | N/A |
| TOTAL | $3,078,500 | $2,655,800 | $1,878,900 | $2,185,700 | $1,827,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,419,000 | 5,789,800 | 5,990,900 | 6,344,600 | 5,300,000 |
| Deferred Revenues | 506,500 | 451,000 | 356,400 | 380,800 | 176,000 |
| Other Non-Current Liabilities | 1,223,800 | 998,800 | 352,900 | 457,300 | 406,100 |
| TOTAL | $7,556,600 | $7,823,600 | $7,335,000 | $7,683,200 | $6,913,600 |
| Total Liabilities | $10,635,100 | $10,479,400 | $9,213,900 | $9,868,900 | $8,741,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,600 | 97,300 | 98,600 | 101,900 | 102,300 |
| Common Shares | 9,000 | 9,000 | 11,700 | 12,000 | 12,100 |
| Retained earnings | 9,479,200 | 7,903,600 | 7,079,800 | 6,196,100 | 4,955,800 |
| Other shareholders' equity | -161,900 | -372,400 | -463,200 | -333,800 | -580,800 |
| TOTAL | $9,436,600 | $7,567,000 | $6,971,400 | $6,804,100 | $5,505,800 |
| Total Liabilities And Equity | $20,071,700 | $18,046,400 | $16,185,300 | $16,673,000 | $14,247,000 |